Fosun Pharma Unit Inks $533M Deal To Sell Medical IP Rights
Shanghai Fosun Pharmaceutical Group Co. Ltd. subsidiary Chongqing Fochon Pharmaceutical Co. Ltd. will sell intellectual property rights to two medical compounds believed to be the early makings of diabetes and cancer...To view the full article, register now.
Already a subscriber? Click here to view full article